Illingworth Research Group wins ‘prestigious’ Queen’s Award
Company recognised with a 2021 Queen’s Award for Enterprise for International Trade
Syneos Health company Illingworth Research Group has been recognised with a 2021 Queen’s Award for Enterprise for International Trade, making it one of 205 UK-based organisations to win this award.
Illingworth Research Group provides clinical research home health services, employing over 200 people across the world. The company, which was established in 1998, was acquired then by Syneos last December.
“We are all incredibly proud to be honoured with this prestigious award for our sustained achievements and consistent growth,” said John Illingworth, chairman, Illingworth Research Group.
Illingworth Research Group Recognized with Queen’s Award for Enterprise: International Trade 2021
MORRISVILLE, N.C., April 30, 2021 (GLOBE NEWSWIRE) The Illingworth Research Group, a Syneos Health
® company, has been recognized with a 2021 Queen’s Award for Enterprise for International Trade. Illingworth Research Group™ is a leading global provider of clinical research home health services. With healthcare already becoming more local, COVID-19 has accelerated the need for in-home clinical trial services which have realized increasing demand in recent years.
Illingworth is one of only 205 UK-based organizations to be recognized with the prestigious Queen’s Award. With this acknowledgement, Illingworth Research becomes the first organization to be awarded the highly acclaimed industry SCRIP Award as Best Specialist Provider, and a Queens Award for Enterprise: International Trade, in the same year.